Infectious Disease Risk Screening Agent
Infectious Disease Risk Screening Agent
This AI agent conducts structured symptom assessments and risk factor screening for COVID-19 and other infectious diseases through a guided conversational flow. Originally developed during the pandemic in partnership with Apollo Hospitals, it captures exposure history, symptom severity, comorbidity data, and travel information to generate a risk profile and direct patients to the appropriate level of care. Infectious disease screening remains a persistent operational challenge for health systems: the CDC reported over 927 million outpatient visits in the U.S. in 2022 alone, and respiratory illness surges continue to strain triage capacity every season. Automating the initial screening step lets clinical staff focus on patients who need hands-on evaluation rather than spending time on repetitive intake questionnaires.
Infectious Disease Risk Screening Agent
Deploying an AI screening agent delivers quantifiable improvements in triage efficiency, clinical resource allocation, and patient throughput during both routine operations and surge events.
During the initial COVID-19 wave, hospital call centers were overwhelmed with screening inquiries, with some systems reporting 10-20x normal call volume within days. An AI screening agent handles unlimited concurrent conversations, processing thousands of risk assessments simultaneously without adding headcount. Health systems that deployed digital pre-screening during the pandemic reported handling 5,000 to 50,000 screenings per day through automated channels, work that would have required hundreds of additional triage staff to manage by phone. Even outside surge conditions, automating routine screening frees clinical staff to focus on patients who need direct clinical evaluation.
When patients complete risk screening before contacting or arriving at a facility, clinicians receive a structured risk profile that accelerates clinical decision-making. Instead of repeating a 10-15 minute intake questionnaire, the care team can move directly to clinical assessment. Studies from the pandemic period showed that digital pre-screening reduced emergency department door-to-decision time by 15-25 minutes per patient. For facilities processing hundreds of patients daily, that time savings compounds into meaningful improvements in throughput and patient experience scores.
A significant portion of patients seeking screening during infectious disease surges are low-risk and do not require in-person evaluation. During COVID-19, estimates suggested that 60-70% of individuals seeking screening could be safely triaged to home monitoring with clear follow-up criteria. By providing accurate, protocol-aligned risk assessments digitally, the agent diverts low-risk patients away from overburdened facilities while ensuring high-risk patients are routed to care immediately. This load-balancing effect protects facility capacity for patients who need it most and reduces exposure risk in waiting areas.
Infectious Disease Risk Screening Agent
features
Built to handle the complexity of infectious disease triage at scale, from individual patient interactions to population-level surge management.
Infectious disease screening is not a linear checklist. A patient with a dry cough and loss of taste requires different follow-up questions than one with gastrointestinal symptoms and recent international travel. The agent uses conditional logic to adapt the assessment in real time, asking follow-up questions based on prior answers. This mirrors how a trained triage nurse conducts an assessment, but without the capacity constraint. During COVID-19 surges, health systems handling tens of thousands of screening requests per day could not staff enough triage nurses to keep up with demand. An AI agent removes that bottleneck entirely.
Effective infectious disease screening goes beyond current symptoms. The agent captures detailed exposure data: known contact with confirmed cases, attendance at high-risk gatherings, recent travel to areas with active outbreaks, and occupational risk factors such as healthcare or congregate-setting employment. This epidemiological context is critical for accurate risk stratification and is the data most often missing from patient self-reported intake forms. Structured capture ensures public health teams get complete, consistent data rather than freeform notes that require manual interpretation.
Patients with underlying conditions face significantly elevated risk from infectious diseases. The agent screens for relevant comorbidities including diabetes, cardiovascular disease, chronic respiratory conditions, immunosuppression, and obesity. The CDC has identified over 30 conditions that increase risk for severe COVID-19 outcomes, and similar comorbidity risk profiles apply to influenza, RSV, and other respiratory pathogens. By capturing this data upfront, the agent ensures that high-risk individuals are flagged for priority follow-up rather than receiving generic guidance.
Infectious disease outbreaks disproportionately affect communities with limited English proficiency and reduced access to healthcare information. The agent can be configured in multiple languages, ensuring screening reaches the populations that need it most. During the COVID-19 pandemic, language barriers were identified as a significant contributor to delayed testing and care-seeking among immigrant and refugee communities. A conversational screening agent that operates in a patient's preferred language removes one of the most persistent barriers to equitable public health response.
Infectious Disease Risk Screening Agent
Get your organization's risk screening AI agent live quickly, with no custom development or IT project required.
Infectious Disease Risk Screening Agent
FAQs
The agent applies the same structured screening criteria that trained triage professionals use: symptom checklists, exposure history questions, comorbidity evaluation, and severity thresholds aligned to CDC or WHO guidelines. It does not diagnose. It risk-stratifies. The output is a structured risk classification that directs patients to the appropriate next step, whether that is testing, telehealth consultation, self-isolation with monitoring, or emergency care. The accuracy of the screening depends on the clinical protocols configured into the agent, which your medical team controls.
Yes. Tars is HIPAA compliant, SOC 2 Type 2 certified, GDPR compliant, and ISO certified. All patient data collected during the screening conversation, including symptoms, exposure history, comorbidities, and personal health information, is encrypted in transit and at rest. Tars supports Business Associate Agreements for healthcare organizations that require them. This compliance framework is essential for any screening tool that collects protected health information, whether deployed by a hospital system, public health department, or employer health program.
Yes. The screening logic is fully configurable through the Tars platform without requiring developer involvement. When the CDC updates its screening criteria, when a new variant emerges with different symptom profiles, or when your organization adopts revised protocols, your team can update the agent's questions, branching logic, and risk thresholds directly. During the pandemic, organizations that relied on static screening forms struggled to keep pace with rapidly evolving guidelines. A configurable AI agent can be updated and redeployed within hours rather than weeks.
The agent handles unlimited concurrent conversations. There is no queue, no hold time, and no capacity ceiling. During a surge event, whether it is a seasonal flu spike, a new COVID-19 wave, or an emerging infectious disease outbreak, the agent can process thousands of screenings simultaneously while maintaining consistent, protocol-aligned assessment quality. This is the fundamental advantage over phone-based or in-person triage: capacity scales instantly without staffing decisions, hiring timelines, or overtime costs.
Yes. Tars offers 600+ integrations including connections to CRMs like HubSpot and Salesforce, spreadsheet tools like Google Sheets, and webhook-based integrations that can push screening data to EHR systems such as Epic, Cerner, or Athenahealth. Screening results, risk classifications, and patient-reported data flow into your existing systems via Zapier or custom API connections, creating a structured record that clinicians can review before engaging the patient and that supports public health surveillance reporting.
While this agent was originally developed for COVID-19 risk screening, the underlying architecture is fully adaptable to any infectious disease screening protocol. Organizations have configured similar agents for influenza, RSV, monkeypox, and tuberculosis screening. The branching logic, symptom libraries, and risk classification thresholds are all configurable, so the same agent framework can be repurposed as new public health screening needs emerge. Health systems that invested in COVID screening infrastructure now have a reusable platform for any future infectious disease response.
Yes. During the pandemic, many employers deployed daily health screening questionnaires for employees returning to on-site work. This agent can be configured for workplace screening, capturing symptoms, exposure events, vaccination status, and travel history. Results can be routed to occupational health teams or HR systems. For industries with specific OSHA or regulatory screening requirements, such as healthcare, food processing, or education, the agent ensures consistent, documented compliance with screening mandates across all employees and shifts.
Most organizations go live within days. You configure the screening questions, branching logic, risk thresholds, and result routing using the Tars visual editor. No coding or IT project is required. The agent can be embedded on your website, shared via SMS or email as a direct link, posted as a QR code at facility entrances, or deployed through WhatsApp. During the initial COVID-19 response, organizations deployed functional screening agents within 48-72 hours of deciding to implement digital triage.
Privacy & Security
At Tars, we take privacy and security very seriously. We are compliant with GDPR, ISO, SOC 2, and HIPAA.
Email - sales@hellotars.com
.png)
%201.png)
%201.png)
